Bench monitoring check: gene-editing cohort breaks out, MRNA/VRTX take the extreme tier, laggard-quality digestion continues

Event

Bench monitoring check: gene-editing cohort breaks out, MRNA/VRTX take the extreme tier, laggard-quality digestion continues

Summary

  • Type: monitoring-check - event_id: 2026-07-07-biotech-capital-cycle-bench-monitoring-check - Source: ; ; perspective data table (2026-07-06 close). MRNA (RSI 81.9, +71.9% 30D, +114.7% vs VWAP) is now the single most parabolic name in the entire desk biotech-scan, with VRTX (RSI 81.6, near ATH) joining it in the ex
3 events
DateTypeEvent
Jul 9 Desk NoteABCL — watch above $8.45 Jul 2 Tweetsector rotation: Tech red → Healthcare/Financials leading (+ 25 bio names) Jul 13 Desk NoteVertical: Biotech Capital Cycle — the theme is confirmed; the question is now entries

No direct external sources are attached to this read.